COVID-19 Monoclonal Antibodies: Key Issues After Emergency Use Authorization

COVID-19 mAbs: Key Issues After EUA

White Paper

COVID-19 Monoclonal Antibodies: Key Issues After Emergency Use Authorization

Published date

November 16, 2020

Duke-Margolis Affiliated Authors

morgan romine

Morgan Romine, MPA

Chief of Staff
Senior Team Member

MHL

Marianne Hamilton Lopez, PhD, MPA

Senior Research Director, Biomedical Innovation
Faculty Director of the Duke-Margolis Postdoctoral Associates & Affiliated Fellows Program
Adjunct Associate Professor
Senior Team Member
Margolis Core Faculty

nitzan arad

Nitzan Arad

Assistant Research Director

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty